Search results
Vertex (NASDAQ:VERX) Shares Gap Down on Analyst Downgrade
ETF DAILY NEWS· 5 days agoShares of Vertex, Inc. (NASDAQ:VERX – Get Free Report) gapped down prior to trading on Tuesday after Citigroup lowered their price target on the stock from $34.00 to $32.00 ...
Vertex has top orphan drug in the pipeline, as pharma eyes shiny obesity drugs: report
FierceBiotech· 6 days agoVertex’s cystic fibrosis triple combo is poised to become the top selling orphan drug in terms of...
Health Care Roundup: Market Talk
The Wall Street Journal· 6 days agoRead about Vertex Pharmaceuticals, cannabis sales, Novartis and more in the latest Market Talks covering the Health Care sector.
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE...
Napa Valley Register· 7 days agoVertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics today announced that Vertex has obtained an exclusive license to TreeFrog's ...
Vertex (NASDAQ:VERX) Sees Strong Trading Volume
ETF DAILY NEWS· 4 days agoVertex, Inc. (NASDAQ:VERX – Get Free Report) saw unusually-high trading volume on Wednesday . The Goldman Sachs Group upped their target price on shares of Vertex ...
Vertex, Inc. Announces Pricing of Upsized $300 Million Convertible Senior Notes Offering - Vertex...
Benzinga· 6 days agoVertex, Inc. VERX ("Vertex"), a leading global provider of indirect tax solutions, today announced the pricing of $300 million aggregate principal amount ...
EU expands cystic fibrosis treatment for infants with KALYDECO By Investing.com
Investing.com· 3 days agoVertex Pharmaceuticals (NASDAQ:VRTX) has announced the European Commission's approval to expand the...
Vertex (NASDAQ:VERX) Price Target Cut to $32.00
ETF DAILY NEWS· 5 days agoA number of other research firms have also issued reports on VERX. The Goldman Sachs Group raised their price target on shares of Vertex from $33.00 to $39.00 and gave the ...
Vertex (NASDAQ:VERX) PT Lowered to $34.00
ETF DAILY NEWS· 5 days agoVertex (NASDAQ:VERX – Get Free Report) had its target price dropped by research analysts at Bank of America from $40.00 to $34.00 in a research note issued on Tuesday, Benzinga ...
Sigma Planning Corp Sells 1,061 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
ETF DAILY NEWS· 5 days agoSigma Planning Corp cut its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 37.3% during the 4th quarter, according to its most recent Form ...
